SYNHUnknown

Syneos Health, Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for Syneos Health, Inc. (SYNH), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are SYNH insiders buying or selling?

Syneos Health, Inc. insiders reported 5 open-market buys ($873.5K) and 117 sells ($17.9B) across 122 Form 4 filings — a net selling position of $17.9B.

Source: SEC EDGAR Form 4

Key Statistics (as of Jul 29, 2022)

Total Form 4 filings
122
SEC EDGAR
Insider filers
15
Insider buys (5)
$873.5K
Insider sells (117)
$17.9B

Insider sentiment

Net selling

Net insider flow of $17.9B in net selling.

Recent SYNH insider transactions

DateInsiderRoleTypeSharesPriceValue
Jul 29, 2022Michael Lee BrooksChief Operating OfficerSale1.5K$78.00$117.2K
Jul 22, 2022Michael Lee BrooksChief Operating OfficerSale1.5K$76.00$114.2K
Jul 21, 2022Jonathan OlefsonGeneral Counsel & Corp SectySale2.2K$75.00$166.1K
Jul 20, 2022Michael Lee BrooksChief Operating OfficerSale1.5K$74.00$111.1K
Jul 20, 2022Michelle KeefeChief Executive OfficerSale8.3K$72.81$606.7K
Jul 20, 2022Jason M. MeggsChief Financial OfficerSale7.5K$72.81$546.1K
Jul 11, 2022Donna Hildebrand KralowetzEVP, Chief Accounting OfficerSale1.1K$73.16$84.1K
Jun 2, 2022Matthew E. MonaghanDirectorSale200$74.35$14.9K
Feb 2, 2022Donna Hildebrand KralowetzSVP, Chief Accounting OfficerSale1.1K$90.00$95.0K
Jan 3, 2022Michael Lee BrooksChief Development Officer, Clinical SolutionsSale93$103.00$9.6K
Dec 27, 2021Jonathan OlefsonGeneral Counsel & Corp SectySale1.9K$100.95$190.7K
Dec 23, 2021Michael Lee BrooksChief Development Officer, Clinical SolutionsSale93$99.00$9.2K
Dec 21, 2021Linda S HartyDirectorSale4.1K$97.02$399.9K
Sep 8, 2021Donna Hildebrand KralowetzSVP, Chief Accounting OfficerSale248$94.30$23.4K
Sep 3, 2021Jason M. MeggsChief Financial OfficerSale9.2K$95.00$876.2K
Aug 4, 2021Alistair MacdonaldChief Executive OfficerSale40.3K$88.19$3.6M
Jul 19, 2021Matthew E. MonaghanDirectorSale170$88.64$15.1K
Jul 7, 2021Jason M. MeggsChief Financial OfficerSale660$90.00$59.4K
Jul 2, 2021Jason M. MeggsChief Financial OfficerSale4.7K$90.00$420.1K
Jun 21, 2021Donna Hildebrand KralowetzSVP, Chief Accounting OfficerSale590$85.03$50.2K
Jun 9, 2021John L. MaldonadoDirectorSale6.3M$81.20$512.2M
Jun 9, 2021Tom AllenDirectorSale6.3M$81.20$512.2M
Jun 9, 2021ADVENT INTERNATIONAL CORP/MA10% OwnerSale6.3M$81.20$512.2M
Jun 9, 2021ADVENT INTERNATIONAL CORP/MA10% OwnerSale6.3M$81.20$512.2M
Jun 9, 2021ADVENT INTERNATIONAL CORP/MA10% OwnerSale6.3M$81.20$512.2M

Showing the 25 most recent of 122 Form 4 filings for Syneos Health, Inc..

Most active SYNH insiders

  • ADVENT INTERNATIONAL CORP/MA42 filings
  • THOMAS H. LEE ADVISORS, LLC16 filings
  • Alistair Macdonald11 filings
  • Jason M. Meggs10 filings
  • Michelle Keefe7 filings

Ask anything about SYNH insider activity

Use Trabud's AI agent to query Syneos Health, Inc.'s Form 4 history in plain English — "Show me SYNH CEO purchases this year" or compare it against any other ticker.

Open the AI agent

SYNH insider trading FAQ

Are Syneos Health, Inc. insiders buying or selling?

Across 122 SEC Form 4 filings, Syneos Health, Inc. (SYNH) insiders reported 5 open-market purchases totaling $873.5K and 117 sales totaling $17.9B. That is a net selling position of $17.9B.

How many insiders trade SYNH stock?

15 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Syneos Health, Inc.. The most recent filing was accepted on Jul 29, 2022.

Where does Trabud get SYNH insider trading data?

All SYNH insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content